期刊文献+

RP-HPLC法测定盐酸利多卡因注射液含量—中国药典(2000版)和美国药典(27版)方法的比较 被引量:3

The determination of the content of lidocaine by RP-HPLC:comparison of the determination method of ChP(2000 version) and USP(27 version)
下载PDF
导出
摘要 目的用反相高效液相色谱法(RP-HPLC)测定盐酸利多卡因注射液含量,并将中国药典(2000版)与美国药典(27版)两种方法进行比较. 方法用两国药典方法(反相高效液相色谱法)测定盐酸利多卡因注射液含量.中国药典(2000版)色谱条件:C18柱,以醋酸钠溶液-甲醇(40:60)为流动相,检测波长254 nm.美国药典(27版)色谱条件:C18柱,以醋酸钠溶液-乙腈(4:1)为流动相,检测波长254nm.结果中国药典(2000版)方法盐酸利多卡因在0.1~3.0 g·L-1浓度范围内,浓度与峰面积线性关系良好,相关系数r=0.999 9.美国药典(27版)方法盐酸利多卡因在0.1~3.0 g·L-1浓度范围内,浓度与峰面积线性关系良好,相关系数r=0.999 8.结论二者盐酸利多卡因浓度与峰面积均具有良好的线性关系,峰面积相差不大,无明显差别. Aim The content of lidocaine was determined by RP-HPLC of different mobile phase with comparison of Chp( 2000 version) and USP(27 version). Methods The content of lidocaine was determined by using the RP-HPLC method. The chromatographic conditions at the Chp included the C18 s column and the mobile phase was composed of sodium acetate-methanol (40: 60). The detection wavelength was 254 nm. The chromatographic conditions at the USP included the C18 column and the mobile phase was composed of sodium acetate - acetonitrile (4:1 ). The detection wavelength was 254 nm. Results The linearity was obtained over 0.1 - 3.0 g·L^-1 ( r = 0.999 9 ) for lidocaine at the Chp (2000 version ) and the linear relation was good. At the USP(27 version) the linearity was obtained over 0.1 -3.0 g·L^-1 ( r = 0. 9998) and the linear relation was good. Conclusion The two linear relations were very good with the density and the peak area. By compareson with the USP,the peak area of the ChP is similar. There is no distinct differences between the two methods.
出处 《安徽医药》 CAS 2005年第9期666-667,共2页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献3

二级参考文献8

  • 1Hwang IK, Morikawa T. Design issues in noninferiority/equivalence trials[J]. Drug Inf J, 1999,33 : 1205 - 1218.
  • 2Chuang SC. Clinical equivalence a clarification[J]. Drug Inf J,1999,33:1189- 1194.
  • 3国家药典委员会.中华人民共和国药典[S].北京:化学工业出版社,2000.正文品种:425
  • 4USP. 26 version. 2003. 708.
  • 5Cakir-B, Tosun-Au. Quantitative high performance liquid chromatogra-phic determination of famotidine in pharmaceutical dosage forms. PHARM-SCI, 1997,580 80 ;3/10:493 - 5.
  • 6Shunmei-z, Weili-L. Determination of famotidine and its preparations by HPLC. CHIN-J-PHARM-ANAL. 1993,13/3:150 - 2.
  • 7刘玉秀,姚晨,陈峰,陈启光,苏炳华,孙瑞元.非劣效性/等效性试验中的统计学分析[J].中国临床药理学杂志,2000,16(6):448-452. 被引量:32
  • 8刘玉秀,姚晨,陈峰,陈启光,苏炳华.非劣性/等效性试验的样本含量估计及统计推断[J].中国新药杂志,2003,12(5):371-376. 被引量:36

共引文献36

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部